Real-world use of biologics for non-systemic juvenile idiopathic arthritis: information from a Japanese hospital claims database
Abstract Objectives Limited information is available on patients with non-systemic juvenile idiopathic arthritis (nsJIA) receiving biologics in Japan. The types of biologics, treatment duration, prior and concomitant treatments, administration routes (intravenous [IV] or subcuta…